December 20, 2017 Comments Off on New patent expiration for Bristol-myers Squibb drug EVOTAZ Posted in: Uncategorized
Annual Drug Patent Expirations for EVOTAZ Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Bristol-myers Squibb drug EVOTA…
December 20, 2017 Comments Off on New patent expiration for Bristol Myers drug REYATAZ Posted in: Uncategorized
Annual Drug Patent Expirations for REYATAZ Reyataz is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from six suppliers. There are two…
The post New patent expiration for Bristol Myers drug REYATAZ appeared f…